Tuesday, January 31, 2023
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
Daily Remedy
  • Home
  • Articles
  • Podcasts
    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    November 25, 2022
    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    November 25, 2022
    A conversation with Dr. Edwin Leap, physician writer and emergency medicine physician

    A conversation with Dr. Edwin Leap, writer and emergency medicine physician

    November 8, 2022
    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    October 31, 2022
    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    October 23, 2022
    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    October 23, 2022
  • Surveys

    Surveys

    Does inflation affect how you use your deductible?

    Does inflation affect how you use your deductible?

    by Jay K Joshi
    December 12, 2022

    Survey Resutls

    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    October 16, 2022
  • About Us
  • Contact us
  • Support Us
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    A conversation with Dr. Selwyn O. Rogers, trauma surgeon and gun policy expert

    November 25, 2022
    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    A conversation with Dr. Kyle Fischer, policy director for the Health Alliance for Violence Intervention

    November 25, 2022
    A conversation with Dr. Edwin Leap, physician writer and emergency medicine physician

    A conversation with Dr. Edwin Leap, writer and emergency medicine physician

    November 8, 2022
    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    A conversation with Mr. Omar M Khateeb, innovator in medical device sales

    October 31, 2022
    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    A conversation with Miss Smriti Kirubanandan, passionate healthcare strategist

    October 23, 2022
    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    A conversation with Mr. Michael Johnson, legal expert in physician contracts

    October 23, 2022
  • Surveys

    Surveys

    Does inflation affect how you use your deductible?

    Does inflation affect how you use your deductible?

    by Jay K Joshi
    December 12, 2022

    Survey Resutls

    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    October 16, 2022
  • About Us
  • Contact us
  • Support Us
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Financial Markets

Arc of Medicare Advantage Plans

Medicare Advantage plans are facing scrutiny after years of excessive billing practices.

Jay K Joshi by Jay K Joshi
November 14, 2022
in Financial Markets
0
Arc of Medicare Advantage Plans

Creative Commons

Healthcare has a way of propping things up just to let them fall. We see things come and go all the time. The latest incumbent to stand on this precarious platform is the Medicare Advantage plan.

The big winners of the Affordable Care Act, Medicare Advantage plans were touted to embody everything right about risk in medicine. Each payer would bid for a regional MA contract, determine how much risk to absorb, and monitor the quality metrics to ensure the risk taken matched the projected clinical outcomes. It seemed like the perfect combination of socialistic compassion and capitalistic enterprise – until it proved otherwise.

At the start of 2021, we saw a trickle of articles reveal how MA plans encouraged physicians to overbill by documenting in excess of the care provided. They noted how MA plans coached physicians to code for more diagnoses to generate more revenue: legitimizing this practice through buzzwords like ‘coding density’.

As the year went on, we saw more articles show how MA plans turned coding and billing into a game that balances the desire for overpayments with the risk of healthcare billing fraud.

Officials have known as early as 2019 that some MA plans overbilled the government by exaggerating how sick their patients were or by billing for treating serious medical conditions they cannot prove their patients had. By the end of that year, it was estimated that MA plans were billing in excess of 30 billion dollars. Yet little was done.

Admittedly, the pandemic had a lot to do with the lack of action. Now that we are passed the acute phase of the pandemic, officials are turning their attention back to this problem of overpayment.

According to MedPAC, a government watchdog panel, the federal government incurred 12 billion dollars in “excess payments” to Medicare Advantage plans in 2020.  MedPAC projected the figure will swell to 16 billion dollars in 2021 (calculations typically lag behind a year), which is already over half of all the overpayments incurred in the previous decade leading up to 2019. Clearly, MA plans used the pandemic as an excuse to push overbilling into overdrive.

Now it seems the MA gravy train is at least slowing. Public perception of MA plans is shifting away from the belief that they represent the future of healthcare delivery to a more grounded understanding that they represent one of many insurance options available.

If we trace the arc of MA plans’ popularity from their evolutionary explosion at the onset of the Affordable Care Act to the present day, then we would conclude we are either at the peak of or just beyond it. This isn’t some half-baked speculation either. There’s a logic to this prediction, and it’s based on trends seen in the past.

Remember HMO’s (Health Maintenance Organizations)? They were all the rage back in the 70s and 80s, just like MA plans are right now. The idea originated with Dr. Paul Ellwood, a pediatric neurologist turned health policy visionary and reformer. He conceived of a self-regulating health care system that aligned physician incentives with patient interests. Sound familiar?

Dr. Ellwood created the first of many integrated delivery systems built on a core of a multi-specialty group practice that linked to hospitals, labs, and pharmacies. The integration allowed Dr. Ellwood to benchmark a fixed reimbursement for care provided throughout the system, with additional profit garnered through lower costs of care. The model required a significant amount of capital as prepayment, but the risk premium came from keeping costs low. It was capitation before we reintroduced the term in the Affordable Care Act. The idea being that by replacing fee-for-service payments with a per capita prepayment, doctors would have an incentive to keep people healthy and to solve their medical problems in less costly ways. Sound familiar?

Of course it does, because conceptually, these models are all the same. Whether the plan is called an ACO, HMO, or MA, the framework is the same: benchmark care delivery with some degree of financial risk. The problem is that payouts don’t align with the delivery of clinical care, just like the quality of a sporting event can’t be determined by the final score.

We think we can match them up, so we concoct fancy financial models to do just that, but we’re consistently wrong. Somehow, somewhere along the way, the compensation veers off. In the heyday of HMOs, we saw a slew of plans fail to cover their expenses and fold. Today, we see a host of venture backed MA payers feast on Medicare dollars like gluttons at a buffet.

The scenarios may appear different, but they all originate from the same cognitive error: we erroneously believe healthcare is an outcome when it is an ongoing series of decisions and behaviors that manifest over time. The clinical metrics measured are wrong because they oversimplify patient care into an outcome.

So, of course we’ll be off financially. The thing is: we’ll likely never learn our lesson. So after we move on from this infatuation with MA plans, we’ll find another innovation that we’ll mint as the savior of healthcare. We’ll prop it up and glamorize it, only to let it fall, just like all the other models before.

ShareTweet
Jay K Joshi

Jay K Joshi

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

YouTube Video VVUxUDVQenU5RTFjUVFKNDY2ZlBmdFB3LmdVUm55WVpqRmNn This is a video about Elemental/Essential Frameworks of Healthcare Law

00:00 Elemental/Essential Frameworks of Healthcare Law
Load More... Subscribe

Expert vs. Lay Testimony

Visuals

NADAC (National Average Drug Acquisition Cost)

NADAC (National Average Drug Acquisition Cost)

by Jay K Joshi
January 29, 2023
0

We list the acquisition price of drugs that are covered under the Medicaid Drug Rebate Program - effectively, how much does the government pay for common drugs utilized by patients on Medicaid. Drugs listed are from A-CH.  

Read more

Twitter Updates

Tweets by DailyRemedy1

Newsletter

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do

Popular

  • Letter to the Alabama Board of Medical Examiners

    Letter to the Alabama Board of Medical Examiners

    0 shares
    Share 0 Tweet 0
  • Malicious Prosecution and Fabrication of Evidence

    0 shares
    Share 0 Tweet 0
  • Prosecuting Doctors as Drug Dealers

    0 shares
    Share 0 Tweet 0
  • My Respect for the Law

    0 shares
    Share 0 Tweet 0
  • Why Our Prescribing were for Patients’ Best Interests

    0 shares
    Share 0 Tweet 0

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Newsletter

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2023 Daily Remedy

No Result
View All Result
  • Home
  • Articles
    • Contrarian
    • Financial Markets
    • Innovations & Investing
    • Perspectives
    • Politics & Law
    • Trends
    • Uncertainty & Complexity
  • Podcasts
  • Surveys
    • Survey Results
  • About Us
  • Contact us
  • Support Us

© 2023 Daily Remedy

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do